News Focus
News Focus
Followers 60
Posts 590
Boards Moderated 0
Alias Born 05/12/2021

Re: MarauderWarlock33 post# 780408

Friday, 08/08/2025 7:58:29 PM

Friday, August 08, 2025 7:58:29 PM

Post# of 828961
You’re spot on, NK cells alone can kill, but without specific targeting, they’re fighting blind. That’s the limitation with a Bioshield-style NK cell–centric approach: you can add more NK cells, but if the tumor has cloaked itself from recognition, they still can’t see it.

Where DCVax Changes the Game

Whether you’re looking at DCVax-L or DCVax-Direct, both start with the patient’s own dendritic cells, the body’s professional antigen-presenting cells, to train the immune system on the tumor’s complete antigen profile. In L, the training is done ex vivo with tumor lysate; in Direct, the cells are partially activated, unloaded, and injected into the tumor to capture antigens in situ. In both cases, once the dendritic cells present those antigens to T cells, the T cells in turn help activate and program NK cells.

Booster Agents Make the Link Stronger

As shown in the Bosch presentation, adding Hiltonol (Poly-ICLC) or other immune-boosting agents can amplify this effect. Poly-ICLC’s TLR3 activation ramps up cytokine and chemokine signaling, which increases NK-cell recruitment and primes them to work in tight coordination with antigen-specific CD8+ killers and CD4+ helpers. In immune profiling after DCVax-L + Poly-ICLC, ~6% of NK cells weren’t just present, they expressed activation markers tied to dendritic-cell communication and antigen-driven programming. The same principle applies to Direct when paired with the right boosters: you not only get more NK cells into the fight, you get trained, tumor-specific NK cells integrated into the whole immune cascade.

Why This Matters

Without the dendritic cell education step, NK cells work off generic stress signals, exactly what tumors learn to suppress. With DCVax, NK cells operate from a tumor-specific “playbook” and as part of a coordinated adaptive + innate strategy. That’s why they can clear “hidden” cancer cells in plain sight, and be ready if the tumor tries to return.

Bottom Line

Bioshield may rent an army. DCVax, L or Direct with the right boosters, trains one, commands it, and integrates every branch of the immune forces for a lasting defense.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News